Sulo, Teresita R.
HRN: 01-59-47 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/25/2025
CEFUROXIME 1.5GM (VIAL)
09/25/2025
10/02/2025
IV
1.5gms
Q8
Acute Appendicitis
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines